Pharmaceutical

SEC Form 8-K Disclosure: Global Pharmaceutical Conglomerate Reports Advanced Clinical Trial Data Breach

Global pharmaceutical enterprise files SEC Form 8-K disclosing a material cyber incident involving unauthorized exfiltration of proprietary Phase 3 clinical trial datasets.